MINOIA, Mariella
 Distribuzione geografica
Continente #
NA - Nord America 2.423
AS - Asia 1.164
EU - Europa 735
SA - Sud America 213
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.560
Nazione #
US - Stati Uniti d'America 2.388
SG - Singapore 458
CN - Cina 365
DE - Germania 199
BR - Brasile 168
UA - Ucraina 133
FI - Finlandia 94
VN - Vietnam 94
HK - Hong Kong 90
GB - Regno Unito 85
TR - Turchia 85
IT - Italia 65
SE - Svezia 41
RU - Federazione Russa 40
FR - Francia 24
AR - Argentina 19
MX - Messico 18
IN - India 16
AT - Austria 13
CA - Canada 13
BD - Bangladesh 11
ZA - Sudafrica 11
PL - Polonia 10
LT - Lituania 9
EC - Ecuador 8
ID - Indonesia 8
IQ - Iraq 8
BE - Belgio 5
ES - Italia 5
JP - Giappone 5
UZ - Uzbekistan 5
AL - Albania 4
CL - Cile 4
CO - Colombia 4
NL - Olanda 4
PK - Pakistan 4
EG - Egitto 3
JO - Giordania 3
PY - Paraguay 3
VE - Venezuela 3
DZ - Algeria 2
EU - Europa 2
KE - Kenya 2
LB - Libano 2
PT - Portogallo 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LK - Sri Lanka 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 4.560
Città #
Singapore 309
Ashburn 291
Woodbridge 246
Chandler 184
Fairfield 178
Houston 175
Jacksonville 147
Santa Clara 121
Beijing 112
Hong Kong 88
Wilmington 82
Ann Arbor 81
Seattle 74
Munich 66
Cambridge 64
Addison 47
Los Angeles 43
Izmir 42
Nanjing 37
Ho Chi Minh City 36
New York 36
Turku 33
Helsinki 32
Dallas 30
Princeton 30
Shanghai 29
Dearborn 27
Boardman 25
Bremen 23
São Paulo 23
Ferrara 20
Hanoi 19
Milan 19
Shenyang 16
Buffalo 14
Nuremberg 14
Brooklyn 13
Denver 13
Jinan 13
Nanchang 13
Changsha 12
Mexico City 12
San Diego 12
Tianjin 11
Chennai 10
London 10
Warsaw 10
Johannesburg 9
Atlanta 8
Falls Church 8
Poplar 8
Chicago 7
Hebei 7
Mountain View 7
Stockholm 7
Ankara 6
Boston 6
Frankfurt am Main 6
Indiana 6
Moscow 6
Auburn Hills 5
Belo Horizonte 5
Brussels 5
Guangzhou 5
Jiaxing 5
Kunming 5
Montreal 5
Orange 5
Orem 5
Tokyo 5
Washington 5
Hefei 4
Hải Dương 4
Jakarta 4
Ningbo 4
Norwalk 4
Osasco 4
Phoenix 4
Quito 4
San Francisco 4
Secaucus 4
Tappahannock 4
Tashkent 4
Vienna 4
Amman 3
Baghdad 3
Campinas 3
Caracas 3
Catalão 3
Da Nang 3
Guarulhos 3
Jackson 3
Karachi 3
Lanzhou 3
Manchester 3
New Delhi 3
Padova 3
Piossasco 3
Rio de Janeiro 3
Rome 3
Totale 3.188
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 242
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 218
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 214
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 212
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 185
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 183
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 174
Growth hormone excess promotes breast cancer chemoresistance 174
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 173
Growth hormone induces chemoresistance in breast cancer cells 171
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 165
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 160
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 155
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 152
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 152
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 151
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 145
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 143
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 142
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 138
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 136
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 130
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 128
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 127
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 122
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 119
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 118
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 88
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  84
null 44
null 40
Totale 4.585
Categoria #
all - tutte 20.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021201 0 0 0 0 0 35 16 41 10 35 42 22
2021/2022288 7 35 13 2 8 18 14 6 6 29 41 109
2022/2023387 33 41 18 55 64 52 20 26 48 4 12 14
2023/2024209 15 16 8 6 18 37 8 53 5 2 2 39
2024/2025797 16 9 50 18 100 120 17 17 111 82 115 142
2025/20261.245 209 109 167 260 385 115 0 0 0 0 0 0
Totale 4.585